Reference health

Informational Shocks and the Effects of Physician Detailing

https://doi.org/10.2139/ssrn.2618835
CiteStamped reference-health badge
44/44 checkable references clean · checked 2026-08-29

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

8 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 44 checked references that resolve
resolves10.1097/mlr.0000000000000329
Antipsychotic Prescribing
resolves10.1016/j.ijindorg.2013.10.005
Pharmaceutical followers
resolves10.1162/105864002320757262
Do Pharmaceutical Sales Respond to Scientific Evidence?
resolves10.1111/1467-6451.00200
Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
resolves10.2139/ssrn.2230976
Off-Label Use of Pharmaceuticals: Trends and Drivers
resolves10.1287/mksc.2015.0925
The Effects of Publicity on Demand: The Case of Anti-Cholesterol Drugs
resolves10.1287/mksc.1030.0029
Strategic Pricing and Detailing Behavior in International Markets
resolves10.1509/jmr.11.0114
New Drug Diffusion when Forward-Looking Physicians Learn from Patient Feedback and Detailing
resolves10.3386/w17528
The Effect of FDA Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts
resolves10.1002/hec.3323
Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence
resolves10.3386/w14634
The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation
resolves10.1509/jmkr.46.2.207
Quantifying the Benefits of Individual-Level Targeting in the Presence of Firm Strategic Behavior
resolves10.1007/s11129-011-9102-7
A new multivariate count data model to study multi-category physician prescription behavior
resolves10.1001/jamainternmed.2015.6058
Association of Off-label Drug Use and Adverse Drug Events in an Adult Population
resolves10.1257/mic.3.1.1
Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration
resolves10.1509/jmkr.47.1.103
Patient-or Physician-Oriented Marketing: What Drives Primary Demand for Prescription Drugs?
resolves10.1016/j.jhealeco.2012.07.006
Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?
resolves10.1509/jmkg.65.3.79.18329
Promotion of Prescription Drugs and Its Impact on Physicians' Choice Behavior
resolves10.1016/s0002-9343(00)00451-4
Incidence and preventability of adverse drug events in nursing homes
resolves10.3386/w17046
Pharmaceutical Use Following Generic Entry: Paying Less and Buying Less
resolves10.1287/mksc.1100.0566
Opinion Leadership and Social Contagion in New Product Diffusion
resolves10.1509/jmkr.46.4.467
Perception Spillovers across Competing Brands: A Disaggregate Model of how and When
resolves10.1287/mnsc.1070.0799
Physicians' Persistence and Its Implications for Their Response to Promotion of Prescription Drugs
resolves10.1287/mksc.1110.0671
Understanding Responses to Contradictory Information About Products
resolves10.1509/jmkr.47.6.1078
Category- versus Brand-Level Advertising Messages in a Highly Regulated Environment
resolves10.1377/hlthaff.2013.0939
Restrictions On Pharmaceutical Detailing Reduced Off-Label Prescribing Of Antidepressants And Antipsychotics In Children
resolves10.1016/s0924-977x(06)70072-4
S.14.04 CATIE trial results
resolves10.1056/nejmoa051688
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
resolves10.1001/jama.292.16.1983
Promotion and Prescribing of Hormone Therapy After Report of Harm by the Women’s Health Initiative
resolves10.1509/jmkr.41.4.467.47005
Response Modeling with Nonrandom Marketing-Mix Variables
resolves10.1287/mnsc.1040.0281
Are Physicians “Easy Marks”? Quantifying the Effects of Detailing and Sampling on New Prescriptions
resolves10.1287/mksc.1100.0570
Dynamic Allocation of Pharmaceutical Detailing and Sampling for Long-Term Profitability
resolves10.1509/jmkr.44.3.503
Estimating Promotion Response When Competitive Promotions Are Unobservable
resolves10.1509/jmkr.47.5.883
Asymmetric Social Interactions in Physician Prescription Behavior: The Role of Opinion Leaders
resolves10.1287/mksc.1080.0410
Heterogeneous Learning and the Targeting of Marketing Communication for New Products
resolves10.1509/jmkr.2005.42.3.278
Temporal Differences in the Role of Marketing Communication in New Product Categories
resolves10.1509/jmkg.68.4.90.42734
Return on Investment Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing-Mix Interactions
resolves10.2105/ajph.70.5.485
A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse.
resolves10.1001/jama.2008.560
Updated Estimates of Pharmaceutical Company Payments to Physicians in Vermont
resolves10.1086/695475
Positive Spillovers and Free Riding in Advertising of Prescription Pharmaceuticals: The Case of Antidepressants
resolves10.1016/j.ijresmar.2013.07.007
The commercial contribution of clinical studies for pharmaceutical drugs
resolves10.1287/mksc.1080.0440
Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes
resolves10.1287/mksc.1120.0757
The Relationship Between DTCA, Drug Requests, and Prescriptions: Uncovering Variation in Specialty and Space
resolves10.1287/mnsc.1070.0718
The Debate on Influencing Doctors' Decisions: Are Drug Characteristics the Missing Link?
The 8 references without a DOI — listed, not checked
no DOI — not checkedAn overview of side eects caused by typical anti-psychotics
no DOI — not checkedUncertainty and the welfare economics of medical care
no DOI — not checkedInformation, marketing, and pricing in the US antiulcer drug market
no DOI — not checkedThe roles of price, quality, and marketing in the growth and composition of the antiulcer drug market
no DOI — not checkedref12
no DOI — not checkedref35
no DOI — not checkedDemand for healthy products: false claims in advertising. Forthcoming
no DOI — not checkedSales territory design: Thirty years of modeling and implementation
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-29 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.2618835"><img src="https://citestamp.com/citestamped/10.2139/ssrn.2618835/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.2618835/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.2618835)